Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosp...

por Gage, Meghan, Putra, Marson, Gomez-Estrada, Crystal, Golden, Madison, Wachter, Logan, Gard, Megan, Thippeswamy, Thimmasettappa
Publicado 2021

Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress

por Gage, Meghan, Putra, Marson, Wachter, Logan, Dishman, Kylie, Gard, Megan, Gomez-Estrada, Crystal, Thippeswamy, Thimmasettappa
Publicado 2021